A new study suggests that a recently approved drug for advanced pancreatic cancer may also be effective against lung cancer. This breakthrough drug has shown promise in treating pancreatic cancer and researchers are now exploring its potential in treating another type of cancer. Further research is needed to confirm the drug's effectiveness, but early results are promising.

The study's findings indicate that the drug may have a broader range of applications than initially thought. For more information on the study and its findings, readers can refer to the original source, which provides additional details on the research and its potential implications for cancer treatment.